Preoperative Identification of a Low-Risk Group for Lymph Node Metastasis in Endometrial Cancer: A Korean Gynecologic Oncology Group Study.
J Clin Oncol / 2012.12
60. Kang S, Kang WD, Jeong DH, Seo SS, Lee JM, Lee JK, Kim JW, Kim SM, Park SY, Kim KT.

Pre-operative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer.
Eur J Nucl Med Mol Imaging / 2014
Cheon GJ, Kim HS, Kim JW, Park NH, Song YS.

Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
Eur J Nucl Med Mol Imaging / 2014.04
Cheon GJ, Kang KW, Kim JW, Park NH, Song YS.

Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer.
Gynecol Oncol / 2013.06
Lee I, Kim HS, Kim JW, Park NH, Song YS, Cheon GJ.
Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer
J Gynecol Oncol / 2012.01
Chung HH, Kwon HW, Kang KW, Kim JW, Park NH, Song YS, Kang SB

One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles
Int J Nanomed / 2013.08
Kim JH, Jeong MS, Song MR, Kang KW, Kim JS

Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer
Ann Surg Oncol / 2012.08
Chung HH, Kwon HW, Kang KW, Park NH, Song YS, Chung JK, Kang SB, Kim JW

Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer
Eur J Radiol / 2012.06
Chung HH, Kang KW, Park NH, Song YS, Chung JK, Kang SB, Kim JW
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Gynecol Oncol / 2011
Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, Song YS, Chung JK, Kang SB

Post-Treatment [18F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma
Eur J Nucl Med Mol Imaging / 2011
Chung HH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB

Post-Treatment [18F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma
Eur J Nucl Med Mol Imaging / 2010
Chung HH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB.

Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.
Am J Obstet Gynecol / 2010
Chung HH, Kang KW, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Chung JK, Kang SB
Preoperative [(18)F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Eur J Nucl Med Mol Imaging. / 2010
Chung HH, Nam BH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB

The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings
Eur J Nucl Med Mol Imaging. / 2008
Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB.

Role of integrated PET/CT in pelvic lymph node staging of cervical cancer before radical hysterectomy
Gynecol Obstet Invest. / 2008
Chung HH, Park NH, Kim JW, Song YS, Chung JK, Kang SB

Role of [(18)F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.
Eur J Nucl Med Mol Imaging / 2007
Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP.
Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma
Gynecol Oncol. / 2007
Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Lee HP

Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence
Gynecol Oncol / 2007
Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP

Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer
Acta Obstet Gynecol Scand / 2007
Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
Gynecol Oncol / 2006
Chung HH, Kim MK, Kim JW, Park NH, Song YS, Kang SB, Lee HP